Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11897879
Heterocyclic compound
granted -
US 11897873
Kappa opioid receptor antagonists and products and methods related thereto
granted -
US 11898180
Compositions and methods for amino acid depletion therapy
granted -
US 11897969
Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury
granted -
US 11898158
Methods and compositions for the treatment of lysosomal storage diseases
granted -
US 11896558
Use of an RXR agonist and taxanes in treating Her2+ cancers
granted -
US 11897845
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 11896617
Polynucleotides encoding rituximab-resistant chimeric antigen receptors
granted -
US 11896643
Fibroblast binding agents and use thereof
granted -
AU 2022206771
Drug conjugates comprising antibodies against Claudin 18.2
granted -
US 11890320
CLEC11A is a bone growth agent
granted -
US 11890307
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11891638
Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)
granted -
US 11891442
Compositions and methods for treating age-related diseases
granted -
US 11890225
Devices and methods for slurry generation
granted -
US 11891360
Glycosylated psilocybin derivatives and methods of using
granted -
US 11890289
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted -
US 11890272
Non-sedating dexmedetomidine treatment regimens
granted -
US 11890353
Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies
granted -
US 11890346
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protein
granted -
US 11890340
Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders
granted -
US 11890344
One-step processing of hydrogels for mechanically robust and chemically desired features
granted -
US 11890308
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11891402
Compositions and methods for treating cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.